MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-10-2025
Harrow Health EV - Enterprise Value 2011-2026 | HROW
Annual EV - Enterprise Value Harrow Health
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 515 M | 513 M | 252 M | 260 M | 190 M | 149 M | 55.5 M | 42 M | 69.9 M | 61.2 M | 56.1 M | 27.7 M | 3.15 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 515 M | 3.15 M | 169 M |
EV - Enterprise Value of other stocks in the Drug manufacturers industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Alimera Sciences
ALIM
|
197 M | - | - | $ 142 M |  USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
28.5 M | - | 0.86 % | $ 117 M | USA |
 |
Canopy Growth Corporation
CGC
|
459 M | $ 1.19 | 0.85 % | $ 128 M |  Canada |
 |
Aerie Pharmaceuticals
AERI
|
737 M | - | - | $ 754 M | USA |
 |
AcelRx Pharmaceuticals
ACRX
|
23.6 M | - | 7.5 % | $ 6.35 M | USA |
 |
Cronos Group
CRON
|
3.84 B | $ 2.67 | -0.74 % | $ 1.42 B | Canada |
 |
Agile Therapeutics
AGRX
|
25.3 M | - | 10.11 % | $ 58.2 M | USA |
 |
Catalent
CTLT
|
16.7 B | - | - | $ 11.5 B | USA |
 |
DURECT Corporation
DRRX
|
3.37 M | - | - | $ 50.1 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
10.2 M | - | -0.1 % | $ 2.03 B |  Schweden |
 |
Eagle Pharmaceuticals
EGRX
|
457 M | - | -39.89 % | $ 27.7 M | USA |
 |
HEXO Corp.
HEXO
|
284 M | - | 2.45 % | $ 38.1 M | Canada |
 |
Endo International plc
ENDP
|
-710 M | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
7.15 M | - | - | $ 36.6 M | USA |
 |
Emergent BioSolutions
EBS
|
1.2 B | $ 13.9 | 5.7 % | $ 712 M | USA |
 |
OrganiGram Holdings
OGI
|
456 M | $ 1.68 | 0.6 % | $ 402 M | Canada |
 |
Pacira BioSciences
PCRX
|
1.68 B | $ 26.0 | 2.73 % | $ 1.2 B | USA |
 |
Athenex
ATNX
|
209 M | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
756 M | $ 21.5 | - | $ 2.05 B |  France |
 |
Sonoma Pharmaceuticals
SNOA
|
7.57 M | $ 3.74 | -1.58 % | $ 4.64 M | USA |
 |
Evolus
EOLS
|
1.03 B | $ 5.66 | -4.23 % | $ 351 M | USA |
 |
China Pharma Holdings
CPHI
|
11.1 M | $ 1.35 | 5.88 % | $ 23.6 M |  China |
 |
Sundial Growers
SNDL
|
-2.47 M | $ 1.65 | -1.79 % | $ 3.37 M | Canada |
 |
Jupiter Wellness
JUPW
|
91.9 M | - | - | $ 33.6 M | USA |
 |
Bausch Health Companies
BHC
|
29.9 B | $ 7.9 | 3.47 % | $ 2.88 B | Canada |
 |
Veru
VERU
|
111 M | $ 2.37 | 1.72 % | $ 320 M | USA |
 |
Lannett Company
LCI
|
648 M | - | 1.15 % | $ 7.11 M | USA |
 |
cbdMD
YCBD
|
7.85 M | $ 1.1 | -4.35 % | $ 4.74 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
124 M | $ 5.19 | 9.96 % | $ 73 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
-110 M | - | - | $ 193 M | Canada |
 |
Organogenesis Holdings
ORGO
|
392 M | $ 4.3 | -1.38 % | $ 566 M | USA |
 |
Aurora Cannabis
ACB
|
106 M | $ 4.24 | - | $ 86.3 M | Canada |
 |
PetIQ
PETQ
|
280 M | - | 1.64 % | $ 400 M | USA |
 |
Recro Pharma
REPH
|
220 M | - | -4.76 % | $ 65.3 M | USA |
 |
Perrigo Company plc
PRGO
|
8.73 B | $ 14.59 | -1.19 % | $ 2 B | USA |
 |
ProPhase Labs
PRPH
|
145 M | - | - | $ 5.07 M | USA |
 |
Rockwell Medical
RMTI
|
57.3 M | $ 0.95 | 2.78 % | $ 22.2 M | USA |
 |
Radius Health
RDUS
|
700 M | - | - | $ 1.42 B | USA |
 |
Relmada Therapeutics
RLMD
|
170 M | $ 4.32 | 5.88 % | $ 130 M | USA |
 |
OptiNose
OPTN
|
312 M | - | - | $ 1.08 B | USA |
 |
Assertio Holdings
ASRT
|
141 M | $ 9.43 | -1.05 % | $ 670 M | USA |
 |
PLx Pharma
PLXP
|
73.8 M | - | -27.8 % | $ 2.56 M | USA |
 |
Solid Biosciences
SLDB
|
197 M | $ 5.61 | 2.19 % | $ 229 M | USA |
 |
SCYNEXIS
SCYX
|
91.7 M | $ 0.64 | -0.05 % | $ 30.6 M | USA |
 |
Tricida
TCDA
|
506 M | - | - | $ 3.25 M | USA |
 |
Tilray
TLRY
|
1.96 B | $ 8.99 | -2.92 % | $ 5.56 B | Canada |
 |
TherapeuticsMD
TXMD
|
33.6 M | $ 2.04 | - | $ 21.3 M | USA |
 |
Viatris
VTRS
|
41.3 B | $ 12.46 | 0.48 % | $ 15.1 B | USA |
 |
Zomedica Corp.
ZOM
|
137 M | - | -0.21 % | $ 98 M | USA |